SKI Market

A+| A| A-|

Indian Indices

Sensex

75,415.35 231.99
( 0.31%)

Global Indices

Nasdaq

50,311.43 281.08
(0.56%)

Dow Jones

7,466.66 12.69
(0.17%)

Hang Seng

63,328.42 1,644.28
(2.67%)

Nikkei 225

10,466.07 33.73
(0.32%)

Forex

USD-INR

96.70 0.18
(0.19%)

EUR-INR

112.25 0.09
(0.08%)

GBP-INR

129.69 0.32
(0.24%)

JPY-INR

0.61 0.00
(0.25%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Divis Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

532488

INE361B01024

578.2640535

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DIVISLAB

70.79

182116.76

EPS(TTM)

Face Value()

Div & Yield %

96.91

0.44

Back

corpus ltd

Apollo Pipes reports consolidated net loss of Rs 3.26 crore in the December 2025 quarter

Jan 29,2026

Net loss of Apollo Pipes reported to Rs 3.26 crore in the quarter ended December 2025 as against net profit of Rs 6.21 crore during the previous quarter ended December 2024. Sales declined 19.73% to Rs 247.18 crore in the quarter ended December 2025 as against Rs 307.93 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	247.18	307.93	-20
OPM %	4.86	7.56	-
PBDT	10.15	20.42	-50
PBT	-5.06	8.64	PL
NP	-3.26	6.21	PL

75,415.35 231.99 ( 0.31%)

50,311.43 281.08 (0.56%)

7,466.66 12.69 (0.17%)

63,328.42 1,644.28 (2.67%)

10,466.07 33.73 (0.32%)

96.70 0.18 (0.19%)

112.25 0.09 (0.08%)

129.69 0.32 (0.24%)

0.61 0.00 (0.25%)